Rebase Lifescience Private Limited, a active private limited company, was established on 15 January 2019 in Lalpur, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290GJ2019PTC106089. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹10.00 Cr.
Employing 33 professional, Its leadership includes Miteshkumar Gordhanbhai Patel (Director), Yogesh Shah (Director), Minesh Manharlal Suthar (Director). Past directors included Shitalben Rajendra Kumar Jadvani, Yogesh Shah, Shailesh M Patel. It holds ₹10.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.11 & 12, Block No.6, Nr. Amrut Dairy, Lalpur, Gujarat, 382430.
U24290GJ2019PTC106089
106089
15 January 2019
₹10.00 Cr
₹10.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rebase Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Miteshkumar Gordhanbhai Patel | Director | 15 Jan 2019 | Current |
| Yogesh Shah | Director | 31 May 2024 | Current |
| Minesh Manharlal Suthar | Director | 24 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 09 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rebase Lifescience Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 94.92% increase. The company also saw a substantial improvement in profitability, with a 71.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 1125.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Rebase Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹105,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2021 | State Bank Of India | ₹5.25 Cr | Open |
| 22 Jan 2021 | State Bank Of India | ₹5.25 Cr | Open |
Explore comprehensive loan charge details -
Rebase Lifescience has a workforce of 33 employees as of Mar 19, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rebase Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebase Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rebase Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Yogesh Shah was appointed as a Director was appointed as a Director on 31 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Rebase Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 5.25 Cr with Charge ID 100415278 was registered on 25 Jan 2021. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 5.25 Cr with Charge ID 100415286 was registered on 22 Jan 2021. was documented.
Minesh Manharlal Suthar was appointed as a Director was appointed as a Director on 24 Dec 2020 & has been associated with this company since 5 years 3 days . was recorded as a recent event.
The CIN of Rebase Lifescience Private Limited is U24290GJ2019PTC106089.
Rebase Lifescience Private Limited is headquartered at Plot No.11 & 12, Block No.6, Nr. Amrut Dairy, Lalpur, Gujarat, 382430.
Rebase Lifescience Private Limited was incorporated on 15 January 2019.
The current directors of Rebase Lifescience Private Limited are
The primary industry of Rebase Lifescience Private Limited is Manufacturing.
Rebase Lifescience Private Limited is unlisted.
The authorized capital of Rebase Lifescience Private Limited is ₹10.00 Cr, and the paid-up capital is ₹10.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX